Related Experiment Video
Updated: Oct 14, 2025
08:47
Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
Published on: April 21, 2022
3.6K
Mucopolysaccharidosis patients have reduced functional capacity
Bianca M C Dias1, Fernanda C Lanza2, Jenifer Dos Santos3
1Universidade Federal de São Paulo (EPM-UNIFESP), São Paulo, São Paulo, Brazil.
Pediatric Pulmonology
|November 6, 2021
Summary
Patients with Mucopolysaccharidoses (MPS) exhibit significantly reduced functional capacity and slower heart rate recovery compared to healthy individuals. These findings highlight the physical challenges faced by MPS patients, even with enzyme replacement therapy.
Area of Science:
- Rare diseases
- Metabolic disorders
- Genetics
Background:
- Mucopolysaccharidoses (MPS) are rare genetic disorders.
- Characterized by the intralysosomal accumulation of glycosaminoglycans.
- Leads to multisystemic clinical conditions and physical-functional impairment.
Purpose of the Study:
- To evaluate the functional capacity (FC) of MPS patients.
- To compare the FC of MPS patients with a healthy control group.
- To assess heart rate recovery (HRR) post-exercise in MPS patients.
Main Methods:
- Cross-sectional study involving 19 MPS patients (ages 6-39) and matched controls.
- Functional capacity assessed via Sit-to-Stand Test (SST) and Incremental Shuttle Walk Test (ISWT).
- Heart rate (HR) and Borg rating of perceived exertion measured during ISWT; HRR calculated post-test.
Main Results:
- MPS patients showed significantly longer SST times (p < .01).
- MPS patients covered less distance on ISWT (p < .01) and reported higher Borg scores (p = .02).
- MPS group exhibited slower HRR (32.9 bpm vs. 69.1 bpm; p < .001).
Conclusions:
- MPS patients demonstrate markedly reduced functional capacity compared to healthy peers.
- Impaired heart rate recovery was observed in MPS patients post-exercise.
- These findings underscore the significant physical limitations associated with MPS.
Related Concept Videos
01:22Lysosomal Hydrolases
4.0K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K
01:23Cystic Fibrosis: Pathogenesis
414
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
414
01:23Glycosaminoglycans
5.4K
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
5.4K
01:05Proteoglycans
4.1K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.1K
01:24Cystic Fibrosis: Management
247
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
247
01:20Inborn Errors of Metabolism
328
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
328